Loading clinical trials...
Loading clinical trials...
This 3-year extension study aims at making available the treatment with secukinumab in prefilled syringes (PFS) to patients with ankylosing spondylitis who took part in phase III study CAIN457F2305, d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT01422694 · Arthritis, Spondylitis, Ankylosing
NCT04301128 · Ankylosing Spondylitis, Spondylitis, Ankylosing
NCT05961267 · Arthritis, Rheumatoid, Spondylitis, Ankylosing, and more
NCT03662919 · Arthritis, Rheumatoid, Spondylitis, Ankylosing, and more
NCT04810715 · Posterior Tibial Tendon Dysfunction, Pes Planus, and more
Novartis Investigative Site
Portland, Oregon
Novartis Investigative Site
Duncansville, Pennsylvania
Novartis Investigative Site
Jackson, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions